1. Home
  2. ARWR
  3. ARWR News

Latest Arrowhead Pharmaceuticals Inc. (ARWR) News on September 7, 2024

Arrowhead Pharmaceuticals Stock Climbs on Plans To Seek FDA Approval for New Drug
ARWR

Investopedia

4 days ago

Arrowhead Pharmaceuticals Stock Climbs on Plans To Seek FDA Approval for New Drug

ARWR

MT Newswires

4 days ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday

Arrowhead to file NDA after pivotal rare disease trial meets all endpoints
ARWR

Clinical Trials Arena

5 days ago

Arrowhead to file NDA after pivotal rare disease trial meets all endpoints

ARWR

MT Newswires

5 days ago

Arrowhead Pharmaceuticals Says Phase 3 Study of Plozasiran Met Primary Endpoint

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome
ARWR

Business Wire

6 days ago

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

ARWR

Argus Research

11 days ago

ARWR: What does Argus have to say about ARWR?

ARWR: Two Obesity Assets to Enter the Clinic in 2025…
ARWR

Zacks Small Cap Research

16 days ago

ARWR: Two Obesity Assets to Enter the Clinic in 2025…

Arrowhead Pharmaceuticals to Present New Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome
ARWR

Business Wire

18 days ago

Arrowhead Pharmaceuticals to Present New Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

ARWR

Argus Research

18 days ago

ARWR: Raising target price to $25.00

Zealand, Arrowhead advance obesity drugs; Bluebird narrows guidance
ARWR

BioPharma Dive

23 days ago

Zealand, Arrowhead advance obesity drugs; Bluebird narrows guidance

Arrowhead announces push into obesity space with two gene therapies
ARWR

Pharmaceutical Technology

23 days ago

Arrowhead announces push into obesity space with two gene therapies

ARWR

MT Newswires

24 days ago

Arrowhead Pharmaceuticals to Advance Two Drug Candidates in Clinical Trials on Obesity

Arrowhead Pharmaceuticals to Advance Two New RNAi-Based Obesity Candidates, ARO-INHBE and ARO-ALK7, Into Clinical Studies
ARWR

Business Wire

24 days ago

Arrowhead Pharmaceuticals to Advance Two New RNAi-Based Obesity Candidates, ARO-INHBE and ARO-ALK7, Into Clinical Studies

ARWR

MT Newswires

a month ago

Arrowhead Pharmaceuticals Fiscal Q3 Loss Widens; Secures $500 Million Credit Facility From Sixth Street

ARWR

Associated Press Finance

a month ago

Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results
ARWR

Business Wire

a month ago

Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results

Arrowhead Pharmaceuticals Announces $500 Million Strategic Financing Facility with Sixth Street
ARWR

Business Wire

a month ago

Arrowhead Pharmaceuticals Announces $500 Million Strategic Financing Facility with Sixth Street

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
ARWR

Business Wire

a month ago

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Third Quarter Results
ARWR

Business Wire

a month ago

Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Third Quarter Results

ARWR

Argus Research

a month ago

ARWR: Lowering target price to $23.00

ARWR

Argus Research

2 months ago

ARWR: Lowering target price to $24.00

ARWR

Argus Research

2 months ago

ARWR: Rating decreased to a SELL

ARWR

MT Newswires

2 months ago

HC Wainwright Cuts Price Target on Arrowhead Pharmaceuticals to $60 From $90, Keeps Buy Rating

ARWR: Moving Plozasiran Forward in Phase 3 CVOT…
ARWR

Zacks Small Cap Research

2 months ago

ARWR: Moving Plozasiran Forward in Phase 3 CVOT…

The past three years for Arrowhead Pharmaceuticals (NASDAQ:ARWR) investors has not been profitable
ARWR

Simply Wall St.

2 months ago

The past three years for Arrowhead Pharmaceuticals (NASDAQ:ARWR) investors has not been profitable

ARWR

MT Newswires

2 months ago

Arrowhead Pharmaceuticals to Advance Investigational Medicine Plozasiran Into Late-stage Cardiovascular Study

Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial
ARWR

Business Wire

2 months ago

Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial

ARWR

MT Newswires

2 months ago

Sector Update: Health Care Stocks Advance Monday Afternoon

ARWR

MT Newswires

2 months ago

Arrowhead Says Potential Obesity Treatment Shows 'Promising' Preclinical Results -- Shares Rise

Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE
ARWR

Business Wire

2 months ago

Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities
ARWR

GlobeNewswire

3 months ago

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)
ARWR

Motley Fool

3 months ago

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans
ARWR

CNW Group

3 months ago

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike
ARWR

Investor's Business Daily

3 months ago

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

EPCOR and HAWSCo Enter Ownership Transfer Agreement
ARWR

CNW Group

3 months ago

EPCOR and HAWSCo Enter Ownership Transfer Agreement

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate
ARWR

GlobeNewswire

3 months ago

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

Southwest Airlines stock pops on report of Elliott's $2B stake
ARWR

Yahoo Finance Video

3 months ago

Southwest Airlines stock pops on report of Elliott's $2B stake

ARWR

Business Wire

3 months ago

Form 8.3 - Virgin Money UK plc

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
ARWR

Business Insider

3 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
ARWR

Insider Monkey

3 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
ARWR

Reuters

3 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

ARWR

Insider Monkey

3 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
ARWR

AFP

3 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
ARWR

Investor's Business Daily

3 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
ARWR

The Wall Street Journal

3 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Toronto Pearson conducts annual full-scale emergency exercise
ARWR

CNW Group

3 months ago

Toronto Pearson conducts annual full-scale emergency exercise

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?
ARWR

Benzinga

3 months ago

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?

ARWR

MT Newswires

3 months ago

Arrowhead Pharmaceuticals' Plozasiran Lowers Triglycerides in Phase 3 Trial; Shares Rise

Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome
ARWR

Business Wire

3 months ago

Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome

Arrowhead Pharmaceuticals to Participate in Upcoming June 2024 Conferences
ARWR

Business Wire

3 months ago

Arrowhead Pharmaceuticals to Participate in Upcoming June 2024 Conferences

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
ARWR

Business Wire

3 months ago

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia
ARWR

Business Wire

3 months ago

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia

ARWR

MT Newswires

4 months ago

Arrowhead Pharmaceuticals Lung Disease Treatment Study Shows Lower Serum sRAGE in Asthma Patients

Arrowhead Pharmaceuticals Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma

ARWR

Zacks Small Cap Research

4 months ago

ARWR: Summer Webinar Series to Highlight Development Pipeline…

Arrowhead Pharmaceuticals Reports Substantial Fiscal Q2 Loss, Diverging from Analyst Expectations
ARWR

GuruFocus.com

4 months ago

Arrowhead Pharmaceuticals Reports Substantial Fiscal Q2 Loss, Diverging from Analyst Expectations

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
ARWR

Insider Monkey

4 months ago

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript

ARWR

MT Newswires

4 months ago

UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating

ARWR

MT Newswires

4 months ago

Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2

ARWR

Associated Press Finance

4 months ago

Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results

ARWR

MT Newswires

4 months ago

Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug

Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma

Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars

Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
ARWR

Business Wire

4 months ago

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease

ARWR

Argus Research

4 months ago

ARWR: What does Argus have to say about ARWR?

Turnstone Biologics Appoints William Waddill to its Board of Directors
ARWR

GlobeNewswire

5 months ago

Turnstone Biologics Appoints William Waddill to its Board of Directors

Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses
ARWR

Simply Wall St.

5 months ago

Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses

Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
ARWR

Business Wire

5 months ago

Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo

Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
ARWR

GuruFocus.com

5 months ago

Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
ARWR

Business Wire

5 months ago

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
ARWR

Business Wire

5 months ago

Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data

Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares
ARWR

GuruFocus.com

6 months ago

Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
ARWR

Business Wire

6 months ago

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy

Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic Value
ARWR

Simply Wall St.

6 months ago

Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic Value

Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
ARWR

Business Wire

6 months ago

Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences

Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
ARWR

Simply Wall St.

7 months ago

Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations

ARWR

Zacks Small Cap Research

7 months ago

ARWR: Pipeline Reprioritization to Reduce Cash Burn by up to $100 Million This Fiscal Year

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript
ARWR

Insider Monkey

7 months ago

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript

ARWR

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Arrowhead Pharmaceuticals Inc Earnings Call

ARWR

Associated Press Finance

7 months ago

Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ...
ARWR

GuruFocus.com

7 months ago

Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ...

Landstar System, Inc. (NASDAQ:LSTR) Q4 2023 Earnings Call Transcript
ARWR

Insider Monkey

7 months ago

Landstar System, Inc. (NASDAQ:LSTR) Q4 2023 Earnings Call Transcript

Invesco Advisers, Inc. Announces Addition to Portfolio Management Team for Invesco Municipal Income Opportunities Trust
ARWR

PR Newswire

7 months ago

Invesco Advisers, Inc. Announces Addition to Portfolio Management Team for Invesco Municipal Income Opportunities Trust

Credit Acceptance (CACC) Q4 Earnings and Revenues Top Estimates
ARWR

Zacks

7 months ago

Credit Acceptance (CACC) Q4 Earnings and Revenues Top Estimates

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
ARWR

Zacks

7 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Banco Santander (SAN) Upgraded to Strong Buy: Here's What You Should Know
ARWR

Zacks

7 months ago

Banco Santander (SAN) Upgraded to Strong Buy: Here's What You Should Know

ARWR

Business Wire

7 months ago

Form 8.3 - DX (Group) plc

ARWR

GlobeNewswire

7 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
ARWR

CNW Group

7 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030
ARWR

GlobeNewswire

7 months ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
ARWR

GlobeNewswire

7 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
ARWR

Barrons.com

7 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Curious about RenaissanceRe (RNR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
ARWR

Zacks

7 months ago

Curious about RenaissanceRe (RNR) Q4 Performance? Explore Wall Street Estimates for Key Metrics

ICE Reports Record Total Futures and Options Open Interest with Record Trading Activity in Global Commodities Markets
ARWR

Business Wire

7 months ago

ICE Reports Record Total Futures and Options Open Interest with Record Trading Activity in Global Commodities Markets

DXC Technology (DXC) to Report Q3 Earnings: What to Expect?
ARWR

Zacks

7 months ago

DXC Technology (DXC) to Report Q3 Earnings: What to Expect?

Eagle Materials Inc. Just Recorded A 6.2% EPS Beat: Here's What Analysts Are Forecasting Next
ARWR

Simply Wall St.

7 months ago

Eagle Materials Inc. Just Recorded A 6.2% EPS Beat: Here's What Analysts Are Forecasting Next

Marsh & McLennan Companies, Inc. (NYSE:MMC) Q4 2023 Earnings Call Transcript
ARWR

Insider Monkey

7 months ago

Marsh & McLennan Companies, Inc. (NYSE:MMC) Q4 2023 Earnings Call Transcript

Share on Social Networks: